Linyi Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Linyi Xie has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Fen Xiong
Department of Audiology and Vestibular Medicine, Senior Department of Otolaryngology, Head and Neck Surgery Chinese PLA General Hospital, Medical School of Chinese PLA Beijing China
2 shared publications - Qiuju Wang
Department of Audiology and Vestibular Medicine, Senior Department of Otolaryngology, Head and Neck Surgery Chinese PLA Institute of Otolaryngology, The Sixth Medical Center of Chinese PLA General Hospital Beijing China
2 shared publications Fei Ning
Department of Otolaryngology‐Head and Neck Surgery The First Medical Center of Chinese PLA General Hospital, Medical School of Chinese PLA Beijing China
1 shared publicationGuohui Chen
Department of Otolaryngology‐Head and Neck Surgery The First Medical Center of Chinese PLA General Hospital, Medical School of Chinese PLA Beijing China
1 shared publication- Hongyang Wang
National Center for Liver Cancer, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China
1 shared publication - Hongyang Wang
Senior Department of Otolaryngology Head and Neck Surgery, the 6th Medical Center of Chinese PLA General Hospital Chinese PLA Medical School, 6 Fucheng Road, Beijing, 100048, PR China; State Key Laboratory of Hearing and Balance Science, 28 Fuxing Road, Beijing 100853, PR China; National Clinical Research Center for Otolaryngologic Diseases, 28 Fuxing Road, Beijing 100853, PR China
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (1) , e70179
Identification of a Novel Likely Pathogenic Variant of DIAPH3 Associated With New Phenotype of Sensorineural Hearing Loss
Background: DIAPH3 variants are associated with non‐syndromic autosomal dominant auditory neuropathy 1 (AUNA1). To the best of our knowledge, there are no reports of DIAPH3 variants causing sensorineural hearing loss. Here, we present a family with late‐onset sensorineural hearing loss as an autosomal dominant trait, caused by a novel DIAPH3 variant. Methods: Audiological examinations were conducted on family members. Whole exome sequencing was performed on the proband to detect candidate genes, and Sanger sequencing was used for other available family members to confirm the causative variation. Results: The DIAPH3 c.1472A>G variant was identified as a disease‐causing mutation in a Chinese family with late‐onset hearing loss. Clinically, manifestations were bilateral sensorineural hearing loss (with pure‐tone thresholds broadly correlating with speech discrimination scores), abnormal auditory brainstem response (ABR), and absent distortion product otoacoustic emission (DPOAE), without abnormalities in other organs or systems. Conclusions: We first identified the likely pathogenic variant DIAPH3 c.1472A>G in a Chinese family with non‐syndromic genetic hearing loss. This point mutation of the DIAPH3 gene is associated with late‐onset bilateral sensorineural hearing loss, distinguishing it from the auditory neuropathy previously reported in other studies. Our findings expand the phenotypic spectrum of DIAPH3 ‐related disorders and underscore the importance of integrating genetic, electrophysiological, and molecular data to refine diagnostic and therapeutic strategies.
- 9 January 2026
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (1) , e70179
Open AccessIdentification of a Novel Likely Pathogenic Variant of DIAPH3 Associated With New Phenotype of Sensorineural Hearing Loss
Background: DIAPH3 variants are associated with non‐syndromic autosomal dominant auditory neuropathy 1 (AUNA1). To the best of our knowledge, there are no reports of DIAPH3 variants causing sensorineural hearing loss. Here, we present a family with late‐onset sensorineural hearing loss as an autosomal dominant trait, caused by a novel DIAPH3 variant. Methods: Audiological examinations were conducted on family members. Whole exome sequencing was performed on the proband to detect candidate genes, and Sanger sequencing was used for other available family members to confirm the causative variation. Results: The DIAPH3 c.1472A>G variant was identified as a disease‐causing mutation in a Chinese family with late‐onset hearing loss. Clinically, manifestations were bilateral sensorineural hearing loss (with pure‐tone thresholds broadly correlating with speech discrimination scores), abnormal auditory brainstem response (ABR), and absent distortion product otoacoustic emission (DPOAE), without abnormalities in other organs or systems. Conclusions: We first identified the likely pathogenic variant DIAPH3 c.1472A>G in a Chinese family with non‐syndromic genetic hearing loss. This point mutation of the DIAPH3 gene is associated with late‐onset bilateral sensorineural hearing loss, distinguishing it from the auditory neuropathy previously reported in other studies. Our findings expand the phenotypic spectrum of DIAPH3 ‐related disorders and underscore the importance of integrating genetic, electrophysiological, and molecular data to refine diagnostic and therapeutic strategies.
- Open Access
- 24 November 2022
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 7 (6) , 2095-2102
The audiological characteristics of infant auditory neuropathy patients without otoacoustic emission
Objective: To explore the audiological characteristics of infant auditory neuropathy (AN) patients with cochlear microphonic (CM) recorded but absent otoacoustic emission (OAE), clinically reducing the rate of missed diagnosis of AN.Methods: We retrospectively analyzed the audiological characteristics of infant AN patients in our medical center between 2003 and 2020. A total of 18 infant AN patients were OAE absent group, with CM present and distortion product otoacoustic emission (DPOAE) absent in both ears. A total of 44 infant AN patients were OAE present group, with CM and DPOAE present in both ears.Results: (1) The found age in OAE absent group was 0.9 (0.02) years old, which was younger than 1.11 (1.63) years old in OAE present group (p = .041). (2) The CM threshold of OAE absent group was 80 (10) dB nHL, which was significantly higher (p < .001) than OAE present group. CM amplitude were smaller (p < .05), and CM duration were shorter (p < .05) in OAE absent group. (3) The thresholds of auditory steady‐state response (ASSR) at 0.5, 1, 2, and 4 kHz were 94 (10), 94 (10), 87 (20), and 81 (10) dB HL cg, respectively in OAE absent group, which were higher than those in OAE present group (p < .01).Conclusions: Infant AN patients with CM present and OAE absent showed earlier detection and different audiological performance, which was manifested in ASSR thresholds, audiometric configurations and CM performance. CM thresholds were increased, amplitude and duration were decreased, non‐linearity of I/O function was reduced.Level of Evidence: 4
- 24 November 2022
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 7 (6) , 2095-2102
Open AccessThe audiological characteristics of infant auditory neuropathy patients without otoacoustic emission
Objective: To explore the audiological characteristics of infant auditory neuropathy (AN) patients with cochlear microphonic (CM) recorded but absent otoacoustic emission (OAE), clinically reducing the rate of missed diagnosis of AN.Methods: We retrospectively analyzed the audiological characteristics of infant AN patients in our medical center between 2003 and 2020. A total of 18 infant AN patients were OAE absent group, with CM present and distortion product otoacoustic emission (DPOAE) absent in both ears. A total of 44 infant AN patients were OAE present group, with CM and DPOAE present in both ears.Results: (1) The found age in OAE absent group was 0.9 (0.02) years old, which was younger than 1.11 (1.63) years old in OAE present group (p = .041). (2) The CM threshold of OAE absent group was 80 (10) dB nHL, which was significantly higher (p < .001) than OAE present group. CM amplitude were smaller (p < .05), and CM duration were shorter (p < .05) in OAE absent group. (3) The thresholds of auditory steady‐state response (ASSR) at 0.5, 1, 2, and 4 kHz were 94 (10), 94 (10), 87 (20), and 81 (10) dB HL cg, respectively in OAE absent group, which were higher than those in OAE present group (p < .01).Conclusions: Infant AN patients with CM present and OAE absent showed earlier detection and different audiological performance, which was manifested in ASSR thresholds, audiometric configurations and CM performance. CM thresholds were increased, amplitude and duration were decreased, non‐linearity of I/O function was reduced.Level of Evidence: 4
- Open Access
- 8 October 2021
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Auditory Neuropathy as the Initial Phenotype for Patients With ATP1A3 c.2452 G > A: Genotype–Phenotype Study and CI Management
Objective: The objective of this study is to analyze the genotype–phenotype correlation of patients with auditory neuropathy (AN), which is a clinical condition featuring normal cochlear responses and abnormal neural responses, and ATP1A3 c.2452 G > A (p.E818K), which has been generally recognized as a genetic cause of cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome.Methods: Four patients diagnosed as AN by clinical evaluation and otoacoustic emission and auditory brainstem responses were recruited and analyzed by next-generation sequencing to identify candidate disease-causing variants. Sanger sequencing was performed on the patients and their parents to verify the results, and short tandem repeat-based testing was conducted to confirm the biological relationship between the parents and the patients. Furthermore, cochlear implantation (CI) was performed in one AN patient to reconstruct hearing.Results: Four subjects with AN were identified to share a de novo variant, p.E818K in the ATP1A3 gene. Except for the AN phenotype, patients 1 and 2 exhibited varying degrees of neurological symptoms, implying that they can be diagnosed as CAPOS syndrome. During the 15 years follow-up of patient 1, we observed delayed neurological events and progressive bilateral sensorineural hearing loss in pure tone threshold (pure tone audiometry, PTA). Patient 2 underwent CI on his left ear, and the result was poor. The other two patients (patient 3 and patient 4, who were 8 and 6 years old, respectively) denied any neurological symptoms.Conclusion:ATP1A3 p.E818K has rarely been documented in the Chinese AN population. Our study confirms that p.E818K in the ATP1A3 gene is a multiethnic cause of AN in Chinese individuals. Our study further demonstrates the significance of genetic testing for this specific mutation for identifying the special subtype of AN with somewhat favorable CI outcome and offers a more accurate genetic counseling about the specific de novo mutation.
- 8 October 2021
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Open AccessAuditory Neuropathy as the Initial Phenotype for Patients With ATP1A3 c.2452 G > A: Genotype–Phenotype Study and CI Management
Objective: The objective of this study is to analyze the genotype–phenotype correlation of patients with auditory neuropathy (AN), which is a clinical condition featuring normal cochlear responses and abnormal neural responses, and ATP1A3 c.2452 G > A (p.E818K), which has been generally recognized as a genetic cause of cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome.Methods: Four patients diagnosed as AN by clinical evaluation and otoacoustic emission and auditory brainstem responses were recruited and analyzed by next-generation sequencing to identify candidate disease-causing variants. Sanger sequencing was performed on the patients and their parents to verify the results, and short tandem repeat-based testing was conducted to confirm the biological relationship between the parents and the patients. Furthermore, cochlear implantation (CI) was performed in one AN patient to reconstruct hearing.Results: Four subjects with AN were identified to share a de novo variant, p.E818K in the ATP1A3 gene. Except for the AN phenotype, patients 1 and 2 exhibited varying degrees of neurological symptoms, implying that they can be diagnosed as CAPOS syndrome. During the 15 years follow-up of patient 1, we observed delayed neurological events and progressive bilateral sensorineural hearing loss in pure tone threshold (pure tone audiometry, PTA). Patient 2 underwent CI on his left ear, and the result was poor. The other two patients (patient 3 and patient 4, who were 8 and 6 years old, respectively) denied any neurological symptoms.Conclusion:ATP1A3 p.E818K has rarely been documented in the Chinese AN population. Our study confirms that p.E818K in the ATP1A3 gene is a multiethnic cause of AN in Chinese individuals. Our study further demonstrates the significance of genetic testing for this specific mutation for identifying the special subtype of AN with somewhat favorable CI outcome and offers a more accurate genetic counseling about the specific de novo mutation.